Effects of Anti-Fas Antibodies on Lymphocytes and Other Organs: Preparation of Original and New Monoclonal Antibodies and Amelioration of Systemic Autoimmune Disease

References

• Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989; 169: 747–1756
   Google Scholar
• Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
   PubMed Web of Science ®Google Scholar
• Trauth B. C., Klas C., Peters A. M. J., Matzku S., Moller P., Falk W. K., Debatin M., Krammer P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301–305
   PubMed Web of Science ®Google Scholar
• Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., Li W. M., Richards S., Dhein J., Trauth B. C., Ponsting H., Krammer P. H. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor receptor superfamily: Sequence identity with the Fas antigen. J. Biol. Chem. 1992; 267: 10709–10715
   PubMed Web of Science ®Google Scholar
• Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169–1178
   PubMed Web of Science ®Google Scholar
• Watanabe R., FukunagaBrannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas that mediates apoptosis. Nature 1992; 356: 314–317
   PubMed Web of Science ®Google Scholar
• Takahashi T., Tanaka M., Brannan C. I., Jenkins N. A., Copeland N. G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994; 76: 969–976
   PubMed Web of Science ®Google Scholar
• Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., Mc P. J., ConahMurphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathologic manifestations in several strains. J. Exp. Med. 1978; 148: 1198–1215
   PubMed Web of Science ®Google Scholar
• Cohen P. L., Eisenberg R. A. Lpr and gld. Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991; 9: 243–269
   PubMed Web of Science ®Google Scholar
• Murphy E. D., Roths J. B. Autoimmunity and lymphoproliferation. Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. Genetic Control of Autoimmune Disease, N. R. Rose, P. E. Bigazzi, N. L. Werner. Elsevier North Holland Inc., NY 1979; 207–221
   Google Scholar
• Nose M., Nishimura M., Kyogoku M. Analysis of granulomatous arthritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. Am. J. Pathol. 1989; 135: 271–280
   PubMed Web of Science ®Google Scholar
• Matsumoto K., Yoshikai Y., Asano T., Himeno K., Iwasaki A., Nomoto K. Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J. Exp. Med. 1991; 173: 127–132
   PubMed Web of Science ®Google Scholar
• Zhou T., Bluethmann H., Eldridge J., Brockhaus M., Berry K., Mountz J. D. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J. Immunol. 1991; 147: 466
   PubMed Web of Science ®Google Scholar
• Taniguchi Y., Ito M. R., Yonehara S., Nose M. Role of macrophages in the development of arteritis in MRL strains of mice with a deficit in Fas-mediated apoptosis. Clin. Exp. Immunol. 1996; 106: 26–34
   PubMed Web of Science ®Google Scholar
• Russell J. H., Rush B., Weaver C., Wang R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 1993; 90: 4409–4413
   PubMed Web of Science ®Google Scholar
• Singer G. G., Abbas A. K. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994; 1: 365–371
   PubMed Web of Science ®Google Scholar
• Hanabuchi S., Koyanagi M., Kawasaki A., Shinohara N., Matsuzawa A., Nishimura Y., Kobayashi Y., Yonehara S., Yagita H., Okumura K. Fas and its ligand in general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 1994; 91: 4930–4934
   PubMed Web of Science ®Google Scholar
• Rouvier E. M., Luciani F., Golstein P. Fas involvement in Ca2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 1993; 177: 195–200
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell 1997; 88: 355–365
   PubMed Web of Science ®Google Scholar
• Giordano C., Stasse G., De Maria R., Todaro M., Richiusa P., Papoff G., Ruberti G., Bagnasco M., Testi R., Galluzzo A. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960–963
   PubMed Web of Science ®Google Scholar
• Nishio A., Katakai T., Oshima C., Kasakura S., Sakai M., Yonehara S., Suda T., Nagata S., Masuda T. A possible involvement of Fas-Fas ligand signaling in the pathogenesis of murine autoimmune gastritis. Gastroenterology 1996; 111: 959–967
   PubMed Web of Science ®Google Scholar
• Chervonsky A. V., Wang Y., Wong F. S., Visintin I., Flavell R. A., Matis L. A. The role of Fas in autoimmune diabetes. Cell 1997; 99: 17–24
   Google Scholar
• Sabelko K. A., Kelly K. A., Nahm M. H., Cross A. H., Russell J. H. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 1997; 159: 3096–3099
   Google Scholar
• Ogasawara J., Watanabe F. R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806–809
   PubMed Web of Science ®Google Scholar
• Nishimura Y., Ishii A., Kobayashi Y., Yamasaki Y., Yonehara S. Expression and function of mouse Fas on immature and mature T cells. J. Immunol. 1995; 154: 4395–4403
   PubMed Web of Science ®Google Scholar
• Nishimura Y., Hirabayashi Y., Matsuzaki Y., Musette P., Ishii A., Nakauchi H., Inoue T., Yonehara S. In vivo analysis of Fas antigen-mediated apoptosis. Effects of agonistic anti-mouse Fas monoclonal antibody on thymus, spleen and liver. Int. Immunol. 1997; 9: 307–316
   Google Scholar
• Nishimura Y., MoritaNose M., Inoue T., Yonehara S. Amelioration of systemic autoimmune disease by the stimulation of apoptosis-promoting receptor Fas with anti-Fas mAb. Int. Immunol. 1997; 9: 1793–1799
   PubMed Web of Science ®Google Scholar
• Tanaka M., Suda T., Yatomi T., Nakamura N., Nagata S. Lethal effect of recombinant human Fas ligand in mice pretreated with. Propionibacterium acnes. J. Immunol. 1997; 158: 2303–2309
   PubMed Web of Science ®Google Scholar
• Boldin M. P., Varfolomeev E. E., Pancer Z., Mett I. L., Camonis J. H., Wallach D. A novel protein that interacts with the death domain of Fas/APOl contains a sequence motif related to the death domain. J. Biol. Chem. 1995; 270: 7795–7798
   PubMed Web of Science ®Google Scholar
• Chinnaiyan A. M., O'Rourke K., Tewari M., Dixit V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505–512
   PubMed Web of Science ®Google Scholar
• Yang X., Khosravi R., FarChang H. Y., Baltimore D. Daxx, a novel Fas-binding protein that activates INK and apoptosis. Cell 1997; 99: 1067–1076
   Google Scholar
• Dhein J., Walczak H., Baumler C. K., Debatin M., Krammer P. H. Autocrine T-cell suicide mediated by APO-l/(Fas/CD95). Nature 1995; 373: 438–441
   PubMed Web of Science ®Google Scholar
• Brunner T., Mogil R. J., La D., FaceYoo N. J., Mahboubi A., Echeverri F., Force S. J., Force W. R., Lynch D. H., Ware C. F., Green D. R. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441–444
   PubMed Web of Science ®Google Scholar
• Sju T., Panka D. J., Cui H., Ettinger R., El M., KhatibSherr D. H., Stanger B. Z., Marshak Rothstein A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444–448
   Google Scholar